NCT00562120
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- Pfizer Investigational Site Omaha, Nebraska, United States
Clinical trial condition
Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.
NCT00562120
NCT01748344
NCT01632540
NCT01918956
NCT01648920
NCT01779895
Not specified
NCT00170248
NCT02104284
Not specified
NCT01817790